Broom N J, Cassels R, Cheng H Y, Elder J S, Hannan P C, Masson N, O'Hanlon P J, Pope A, Wilson J M
SmithKline Beecham Pharmaceuticals, Betchworth, Surrey, U.K.
J Med Chem. 1996 Aug 30;39(18):3596-600. doi: 10.1021/jm950882q.
A series of C-1 oxazole isosteres of pseudomonic acid A (mupirocin) bearing a nitroheterocycle have been synthesized, and significant differences in both spectrum of activity and potency were found between these derivatives and mupirocin. Additionally, the antibacterial potency of two members of this class of compounds against mupirocin-resistant staphylococci could not be accounted for solely by inhibition of the target enzyme isoleucyl-tRNA synthetase (IRS), indicating an additional mode of action. The most potent compound, the nitrofuran 3f (SB 205952), was the most electron affinic derivative prepared and was transformed by NAD(P)H-dependent bacterial reductases at a rate similar to that for nitrofurantoin. The second mode of action of this compound may therefore arise from its reduction to a species with cellular targets other than IRS. In in vivo studies, 3f was shown to be a very effective agent by both the subcutaneous and oral routes of administration.
一系列带有硝基杂环的假单胞菌酸A(莫匹罗星)的C-1恶唑电子等排体已被合成,并且发现这些衍生物与莫匹罗星在活性谱和效力方面存在显著差异。此外,这类化合物中的两个成员对耐莫匹罗星葡萄球菌的抗菌效力不能仅通过抑制靶酶异亮氨酰 - tRNA合成酶(IRS)来解释,这表明存在另一种作用模式。最有效的化合物,即硝基呋喃3f(SB 205952),是所制备的最具亲电子性的衍生物,并且被NAD(P)H依赖性细菌还原酶转化的速率与呋喃妥因相似。因此,该化合物的第二种作用模式可能源于其还原为具有除IRS之外的细胞靶点的物质。在体内研究中,3f通过皮下和口服给药途径均显示为非常有效的药物。